-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total costs of sales and operating expenses for the period.
-
Summary
-
Athira Pharma, Inc. quarterly/annual Costs and Expenses history and growth rate from Q3 2019 to Q2 2024.
- Athira Pharma, Inc. Costs and Expenses for the quarter ending June 30, 2024 was $28M, a 11.4% decline year-over-year.
- Athira Pharma, Inc. Costs and Expenses for the twelve months ending June 30, 2024 was $120M, a 1.1% increase year-over-year.
- Athira Pharma, Inc. annual Costs and Expenses for 2023 was $125M, a 20.6% increase from 2022.
- Athira Pharma, Inc. annual Costs and Expenses for 2022 was $104M, a 62.5% increase from 2021.
- Athira Pharma, Inc. annual Costs and Expenses for 2021 was $64M, a 220% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)